Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Non Operating Income: 2020-2025

Historic Non Operating Income for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $395,000.

  • Mirum Pharmaceuticals' Non Operating Income rose 136.34% to $395,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 235.64%. This contributed to the annual value of $1.2 million for FY2024, which is 142.95% up from last year.
  • Mirum Pharmaceuticals' Non Operating Income amounted to $395,000 in Q3 2025, which was up 359.30% from $86,000 recorded in Q2 2025.
  • Mirum Pharmaceuticals' Non Operating Income's 5-year high stood at $2.1 million during Q1 2025, with a 5-year trough of -$3.1 million in Q4 2023.
  • Its 3-year average for Non Operating Income is $88,909, with a median of $231,000 in 2024.
  • Its Non Operating Income has fluctuated over the past 5 years, first slumped by 3,358.82% in 2022, then soared by 788.54% in 2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Non Operating Income (Quarterly) stood at -$17,000 in 2021, then slumped by 3,358.82% to -$588,000 in 2022, then slumped by 420.58% to -$3.1 million in 2023, then spiked by 107.55% to $231,000 in 2024, then surged by 136.34% to $395,000 in 2025.
  • Its Non Operating Income stands at $395,000 for Q3 2025, versus $86,000 for Q2 2025 and $2.1 million for Q1 2025.